Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis

Published:2019-09-05 Issue:3 Volume:43 Page:289-304
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Dorsey-Treviño E. G.^ORCID,González-González J. G.,Alvarez-Villalobos N.,González-Nava V.,Contreras-Garza B. M.,Díaz González-Colmenero A.,Rodríguez-Tamez G.,Barrera-Flores F. J.,Farrell A. M.,Montori V. M.,Rodriguez-Gutierrez R.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s40618-019-01103-9.pdf

Reference81 articles.

1. McKinlay J, Marceau L (2000) US public health and the 21st century: diabetes mellitus. Lancet 356(9231):757–761

2. Zimmet P (2003) The burden of type 2 diabetes: are we doing enough. Diabetes Metab 29(4 Pt 2):6s9-18

3. Singleton JR, Smith AG, Russell JW, Feldman EL (2003) Microvascular complications of impaired glucose tolerance. Diabetes 52(12):2867–2873

4. Fowler MJ (2008) Microvascular and macrovascular complications of diabetes. Clin Diabetes 26(2):77–82

5. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414–1431

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amputation Risk in Type II Diabetes Mellitus Patients Treated with SGLT-2 Inhibitors: A Systematic Literature Review of Randomized Clinical Trials;Drug Research;2024-08-02

2. Treatment adherence and the contemporary approach to treating type 2 diabetes mellitus;Biomedical Papers;2024-06-10

3. Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database;Diabetologia;2024-04-08

4. Safety of sodium-glucose transporter 2 (SGLT-2) inhibitors in patients with type 2 diabetes: a meta-analysis of cohort studies;Frontiers in Pharmacology;2023-10-13

5. Update on Medical Management of Diabetes;Orthopedic Clinics of North America;2023-07